Eli Lilly and Company (LLY) high-risk individuals can now convert to a very simple, easy to administer drug ... Lilly said it will spend $1.8 billion to boost production in Ireland of its popular diabetes and weight-loss ... 09/16/2024 - 4:59 am | View Link
This Big Move by Eli Lilly May Solve the Weight Loss Drug Market's Biggest Problem In fact, demand has been so high that it's been surpassing supply, forcing Lilly and rival Novo Nordisk to invest in additional manufacturing capacity. Recently, Lilly made a new move that could solve ... 09/5/2024 - 9:34 pm | View Link
The Weight Loss Drug That Can Prevent Diabetes Eli Lilly, the makers of tirzepatide—which they sell as Mounjaro for diabetes and Zepbound for weight loss— announced recently that in its longest study yet on tirzepatide, the drug reduced the risk ... 09/4/2024 - 7:48 am | View Link
Eli Lilly: Zepbound Price Cuts Have Multiple Positives, Limited Downside Eli Lilly's weight loss treatment Zepbound might be a blockbuster in the making, but it wasn't without its challenges. See why I continue to rate LLY stock a buy. 09/4/2024 - 12:09 am | View Link
Eli Lilly's weight-loss drug cuts diabetes risk by 94% in three-year trial London: Eli Lilly's weight-loss drug cut the risk of developing type 2 diabetes by 94 per cent in pre-diabetic adults who were overweight or obese after three years of weekly injections ... 08/20/2024 - 1:10 pm | View Link
Japan launches world's first steady-state nuclear fusion reactor in bid to offer limitless energy: 'Up and creating electrical power within the next 10 years'